Solomon Moshkevich $NTRA SEC Form 4 Insider Trading

Solomon Moshkevich has filed a total of 56 insider trades in $NTRA since 2021. Their most recent trade was a sale of 8 shares, made on Aug 14, 2025. Their largest trade was a sale of 53,489 shares, made on Apr 16, 2024. We estimate that they now own 123,859 shares of $NTRA, worth an estimated $19.7 million.

Insider Trading at $NTRA

There have been a total of 897 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 3.7 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 867 shares reported by Solomon Moshkevich (PRESIDENT, CLINICALDIAGNOSTICS), made on Aug 14, 2025.

$NTRA Executives and Stock Owners with Insider Trades

• Steven Leonard Chapman, CEO AND PRESIDENT

• Michael Burkes Brophy, CHIEF FINANCIAL OFFICER

• Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER

• Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS

• Matthew Rabinowitz, EXECUTIVE CHAIRMAN

• Robert Alan Schueren, CHIEF OPERATING OFFICER

• John Fesko, PRESIDENT, CHIEF BUS. OFFICER

• Daniel Rabinowitz, CHIEF LEGAL OFFICER

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.